Clinical Trial Update: Study Evaluating Ovasave, an Autologous Cell Therapy, in Patients With Active Crohn's Disease [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating Ovasave, an autologous cell therapy, for active Crohn's disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Ovasave

Snippet

Sponsor: TxCell | Conditions: Crohn Disease | Phase 2 | Status: TERMINATED